Hom-Lie-Hopf algebras

We studied both the double cross product and the bicrossproduct constructions for the Hom-Hopf algebras of general $(\alpha,\beta)$-type. This allows us to consider the universal enveloping Hom-Hopf algebras of Hom-Lie algebras, which are of $(\alpha,{\rm Id})$-type. We show that the universal enveloping Hom-Hopf algebras of a matched pair of Hom-Lie algebras form a matched pair of Hom-Hopf algebras. We observe also that, the semi-dualization of a double cross product Hom-Hopf algebra is a bicrossproduct Hom-Hopf algebra. In particular, we apply this result to the universal enveloping Hom-Hopf algebras of a matched pair of Hom-Lie algebras to obtain Hom-Lie-Hopf algebras

METU interoperable database system

and Sevgi Foundation, Turkey) is a multidatabase system based on OMG's (OMG is a registered trademark, and CORBA, ORB, OMG IDL, Object Request Broker are trademarks of OMG) distributed object management architecture. It is implemented on top of a CORBA compliant ORB, namely, DEC's ObjectBroker (ObjectBroker is a registered trademark of DEC Corp.) [DDO96]. In MIND all local databases are encapsulated in generic Database Object. The interface of the generic Database Object is de ned in CORBA IDL and multiple implementations of this interface, one for each component DBMSs, namely, Oracle7 (Oracle7 is a trademark of Oracle Corp.), Sybase (Sybase is a trademark of Sybase Corp.), Adabas D (Adabas D is a trademark of Software AG Corp.) and MOOD [Dog94] are provided. MIND provides its users a common data model and a single global query language based on SQL. The main functionalities of MIND are global query processing, global transaction management and schema integration. The basic component classes in the system are

Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects

<p>Abstract</p> <p>Background</p> <p>Although much progress has been made on antipsychotic drug development, precise mechanisms behind the action of typical and atypical antipsychotics are poorly understood.</p> <p>Methods</p> <p>We performed genome-wide expression profiling to study effects of typical antipsychotics and atypical antipsychotics in the postmortem liver of schizophrenia patients using microarrays (Affymetrix U133 plus2.0). We classified the subjects into typical antipsychotics (n = 24) or atypical antipsychotics (n = 26) based on their medication history, and compared gene expression profiles with unaffected controls (n = 34). We further analyzed individual antipsychotic effects on gene expression by sub-classifying the subjects into four major antipsychotic groups including haloperidol, phenothiazines, olanzapine and risperidone.</p> <p>Results</p> <p>Typical antipsychotics affected genes associated with nuclear protein, stress responses and phosphorylation, whereas atypical antipsychotics affected genes associated with golgi/endoplasmic reticulum and cytoplasm transport. Comparison between typical antipsychotics and atypical antipsychotics further identified genes associated with lipid metabolism and mitochondrial function. Analyses on individual antipsychotics revealed a set of genes (151 transcripts, FDR adjusted p < 0.05) that are differentially regulated by four antipsychotics, particularly by phenothiazines, in the liver of schizophrenia patients.</p> <p>Conclusion</p> <p>Typical antipsychotics and atypical antipsychotics affect different genes and biological function in the liver. Typical antipsychotic phenothiazines exert robust effects on gene expression in the liver that may lead to liver toxicity. The genes found in the current study may benefit antipsychotic drug development with better therapeutic and side effect profiles.</p

TLR 9 Activation in Dendritic Cells Enhances Salmonella Killing and Antigen Presentation via Involvement of the Reactive Oxygen Species

Synthetic CpG containing oligodeoxynucleotide Toll like receptor-9 agonist (CpG DNA) activates innate immunity and can stimulate antigen presentation against numerous intracellular pathogens. It was observed that Salmonella Typhimurium growth can be inhibited by the CpG DNA treatment in the murine dendritic cells. This inhibitory effect was mediated by an increased reactive oxygen species production. In addition, it was noted that CpG DNA treatment of dendritic cells during Salmonella infection leads to an increased antigen presentation. Further this increased antigen presentation was dependent on the enhanced reactive oxygen species production elicited by Toll like receptor-9 activation. With the help of an exogenous antigen it was shown that Salmonella antigen could also be cross-presented in a better way by CpG induction. These data collectively indicate that CpG DNA enhance the ability of murine dendritic cells to contain the growth of virulent Salmonella through reactive oxygen species dependent killing